Home ▶ Unknown
Scientific Symposia

Sunday, May 15, 2016
9 - 11 a.m.
A6 Joint ATS/ERS/JRS Symposium on Severe Asthma: A Global Perspective
A7 ATS Mythbuster: Reversing Fibrosis in the Lungs Is Biological Mission (Im)possible
A8 Everything You Ever Wanted to Know About Sex Steroids and Lung Disease
A9 Controversies in Sleep Medicine: Davids, Goliaths, and Some Blood on the Floor!
A10 New Insights into the Pathogenesis and Treatment of Bronchopulmonary Dysplasia
A11 Global Lung Cancer Health Issues
A12 Entrepreneurship: Embracing the Innovative Environment - From Bench to Boardroom to Bedside
2:15 - 4:15 p.m.
A82 Treatment of Early Stage and Screen-Detected Lung Cancer: A Pro/Con Debate
A86 Bringing Order to the Chaos of ACOS (Asthma-COPD Overlap Syndrome)
A87 E-Cigarette Vaping: Preclinical and Clinical Pulmonary Health Effects
A88 Community Acquired Pneumonia in the Elderly Patient
A89 From Beauty to Breaking Bad: Uncovering the World of Drug Induced Pulmonary Hypertension
A90 Abnormal Metabolism: Emerging Concepts in Understanding Lung Disease
A91 Hot Topics in Disparities in Pulmonary, Critical Care and Sleep Medicine
Monday, May 16, 2016
9 - 11 a.m.
B6 Building E-Bridges: Tools at Our Fingertips for Enhancing Collaborative Care
B7 One Step at a Time: Has Physical Activity Delivered as an Outcome in Clinical Trials?
B8 Sleep, Sleep Disorders and Performance in Athletes
B9 Sickle Cell Disease and the Lung Across the Lifespan
B10 New Concepts in Asthma Biology
B11 Scientific Breakthroughs in Sarcoidosis Research and Phenotyping: The NHLBI GRADS Consortium
B12 Global Health: The What, Where and Why in the 21St Century
B13 Applied Physiology Is Alive and Well (President's Symposium)
2:15 - 4:15 p.m.
B86 Immunotherapy for Lung Cancer: Power to the Host
B87 Beyond BMPR2: Emerging Roles of DNA Damage and Somatic Mutation in Pulmonary Arterial Hypertension
B88 Improving Real World Care Through Innovative Trial Designs
B89 Health Effects of Inhaled Toxins: From the Bench to the Trenches: A Global Perspective
B90 New Insights into the Predisposition, Pathogenesis, and Management of Fungal Pneumonia
B91 AJRCCM: Leading Journal in Respiratory, Critical Care and Sleep Medicine. Key Papers, Publication Ethics, New Initiatives
Tuesday, May 17, 2016
9 - 11 a.m.
C5 The Brain After Critical Illness: Populations, Patients, and Pathways
C6 A Report Card on Education During Pulmonary Rehabilitation: How Are We Doing?
C7 Understanding Clinical Trials Data in Pulmonary Arterial Hypertension and Using Those Data in Practice
C8 Breaching Barriers: Targeted Delivery of Therapeutics to the Lung
C9 The Link Between Ciliary Assembly Defects, Neonatal Respiratory Distress and Bronchiectasis in Adulthood: A Primer on Primary Ciliary Dyskinesia
C10 Achieving "Environmental Justice": A Major Step Toward Respiratory Health Equality
C11 Pathogenesis and Treatment of Obstructive Lung Diseases: New Insights
C12 Biomarkers: Guideposts in the Roadmap to Improved Personalized and Precision Medicine
C13 Progress in Stem Cell Biology and Disease Applications
2:15 - 4:15 p.m.
C86 Self-Management and Risk Reduction Challenges in Vulnerable Populations
C87 New Insights into the Genetic Basis of Pediatric Lung Disease
C88 Viral Community-Acquired Pneumonia
C89 Emerging Immune Functions of the Pulmonary Epithelium in Infection, Asthma, and Chronic Lung Disease
C90 It Takes Two to Tango: Right and Left Ventricle Interactions in Pulmonary Vascular Disease
C91 Optimizing ICU Rounds: Evidence-Based Approaches for Improving Patient Care and Teaching
C92 ATS Clinical Practice Guidelines: Clinical Practice on the Cutting Edge
Wednesday, May 18, 2016
9 - 11 a.m.
D5 Improving Our Understanding of Respiratory Symptoms, Refractory Chronic Cough and Interprofessional Management
D6 Cannabis, Cannabimimetics, and Opiates in Sleep and Breathing
D7 Exploiting GPCRs for New and Improved Asthma Medicine
D8 ATS Mythbusters: Aberrant Tissue Regeneration Is a Primary Driver of COPD Pathogenesis
D9 Cracking the Cell Code: Understanding the Contribution of Cells to Pulmonary Vascular Diseases
D10 New Concepts in TB Immunity and Targets for Treatment
D11 ARDs and Inflammatory Injury
D12 Advances in Tobacco Dependence Treatment for the Hospitalized Patient
1:30 - 3:30 p.m.
D85 Early Life Origins of Chronic Disease
D86 Controversies and Advances in the Management of Ventilator Associated Pneumonia
D87 Climate Changes and Respiratory Infections
D88 The Patient-Centered Juggernaut: The Right Move for Clinical Care, Policy, and Research?
D89 Novel Approaches to Treat Pulmonary Infections
D90 Respiratory Health in Migrant Populations